Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.

Herrmann, K.,Czernin, J.,Wolin, E. M.,Gupta, P.,Barrio, M.,Gutierrez, A.,Schiepers, C.,Mosessian, S.,Phelps, M. E.,Allen-Auerbach, M. S.; J. Nucl. Med.. 2014 Dec 17.

Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians.

Karantanis, D.,Kalkanis, D.,Czernin, J.,Herrmann, K.,Pomykala, K. L.,Bogsrud, T. V.,Subramaniam, R. M.,Lowe, V. J.,Allen-Auerbach, M. S.; J. Nucl. Med.. 2014 Dec 03.

Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.

Karantanis, D.,Kalkanis, D.,Allen-Auerbach, M. S.,Herrmann, K.,Pomykala, K. L.,Bogsrud, T. V.,Lowe, V. J.,Czernin, J.; Nuklearmedizin. 2014 Jan 30.